140646-99-7Relevant articles and documents
Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads
Donnell, Andrew F.,Zhang, Yong,Stang, Erik M.,Wei, Donna D.,Tebben, Andrew J.,Perez, Heidi L.,Schroeder, Gretchen M.,Pan, Chin,Rao, Chetana,Borzilleri, Robert M.,Vite, Gregory D.,Gangwar, Sanjeev
supporting information, p. 5267 - 5271 (2017/11/16)
Macrocyclic pyrrolobenzodiazepine dimers were designed and evaluated for use as antibody-drug conjugate payloads. Initial structure–activity exploration established that macrocyclization could increase the potency of PBD dimers compared with non-macrocyclic analogs. Further optimization overcame activity-limiting solubility issues, leading to compounds with highly potent (picomolar) activity against several cancer cell lines. High levels of in vitro potency and specificity were demonstrated with an anti-mesothelin conjugate.
NOVEL CYTOTOXIC AGENTS FOR CONJUGATION OF DRUGS TO CELL BINDING MOLECULE
-
Page/Page column 90, (2015/03/16)
Provided are cytotoxic agents, pyrrolo[2,1-c][1,4]benzodiazepine (PBD) derivatives, their conjugates with a cell-binding agent, the preparation and the therapeutic uses in the targeted treatment of cancers, autoimmune disorders, and infectious diseases.
Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates
Wells, Geoff,Martin, Christopher R. H.,Howard, Philip W.,Sands, Zara A.,Laughton, Charles A.,Tiberghien, Arnaud,Woo, Chi Kit,Masterson, Luke A.,Stephenson, Marissa J.,Hartley, John A.,Jenkins, Terence C.,Shnyder, Steven D.,Loadman, Paul M.,Waring, Michael J.,Thurston, David E.
, p. 5442 - 5461 (2007/10/03)
A novel series of methyl ester-terminated CS-linked pyrrolobenzodiazepine (PBD)-poly(N-methylpyrrole) conjugates (50a-f) has been synthesized and their DNA interaction evaluated by thermal denaturation, DNA footprinting, and in vitro transcription stop assays. The synergistic effect of attaching a PBD unit to a polypyrrole fragment is illustrated by the large increase in DNA binding affinity (up to 50-fold) compared to the individual PBD and pyrrole components. 50a-f were found to bind mainly to identical DNA sequences but with apparent binding site widths increasing with molecular length and the majority of sites conforming to the consensus motif 5′-XGXWz (z = 3 ± 1; W = A or T; X = any base but preferably a purine). They also provided robust sequence-selective blockade of transcription at sites corresponding approximately to their DNA footprints. 50a-f were shown to have good cellular/nuclear penetration properties, and a degree of correlation between cytotoxicity and DNA-binding affinity was observed.